Inogen: Cheap Enough To Take A Chance On

Inogen, Inc. (INGN) is upgraded to Buy, driven by operational improvement with support from a robust balance sheet. INGN's $45m share buyback, debt-free status, and cash/investments covering ~61% of market cap provide downside protection and acquisition appeal. Management turnover and anemic 2026 revenue growth guidance (3% at midpoint) remain risks, but operational improvements are emerging.

Seeking Alpha • Oct 20, 2026

Inogen to Report Third Quarter 2026 Financial Results on November 5, 2026

BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen to Report Third Quarter 2026 Financial Results on November 5, 2026.

Business Wire • Oct 15, 2026

Inogen Announces Divestiture of Its U.S. Oxygen Rental Business to Rotech

BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--INOGEN ANNOUNCES DIVESTITURE OF ITS U.S. OXYGEN RENTAL BUSINESS TO ROTECH.

Business Wire • Sep 30, 2026

Here's Why You Should Retain Inogen Stock in Your Portfolio for Now

INGN's POC demand, new products and international growth support its outlook, while U.S. channel shifts and distributor timing pose risks.

Zacks Investment Research • Aug 21, 2026

Inogen Cuts 2026 Revenue Outlook as U.S. Channel Pressure Persists

INGN cuts its 2026 revenue outlook as U.S. channel pressure weighs, while international growth, new products and cost control offer support.

Zacks Investment Research • Aug 11, 2026

Should Investors Buy Inogen as Low Valuation Meets Execution Risk?

Inogen's steep sales-multiple discount, improving margins and firm international demand clash with U.S. sales and rental weakness.

Zacks Investment Research • Aug 11, 2026

Inogen Q2 Earnings Beat Estimates, Sales Rise Y/Y, 2026 View Cut

INGN's Q2 revenues rise 3% as international sales climb 14.8%, but U.S. weakness led it to cut its 2026 revenue outlook.

Zacks Investment Research • Aug 10, 2026

Inogen, Inc. (INGN) Q2 2026 Earnings Call Transcript

Inogen, Inc. (INGN) Q2 2026 Earnings Call Transcript

Seeking Alpha • Aug 7, 2026

Inogen Q2 Earnings Call Highlights

Inogen NASDAQ: INGN reported second-quarter 2026 revenue of $95.1 million, up 3% from a year earlier, as international growth, portable oxygen concentrator demand and contributions from newer products offset continued pressure in its U.S. direct-to-consumer business.

MarketBeat • Aug 7, 2026

Inogen Announces Second Quarter 2026 Financial Results

BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Reported second quarter revenue of $95.1 million. Company raises full-year adjusted EBITDA guidance to approximately $4.0 million.

Business Wire • Aug 6, 2026